CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Nalox-1 Pharmaceuticals, LLC et al. vs. Opiant Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2019-00699 filed by Nalox-1 Pharmaceuticals, LLC et al. on 2019-02-19. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2019-00699

Filing Date

2019-02-19

Accorded Filing Date

2019-02-19

Institution Decision Date

2019-10-16

Last Modified Date

—

Proceeding Type

IPR

Termination Date

—

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 15589090
Respondent Patent Number 9775838
Legal Expiration Date
2037-05-08 Active (10.5 yrs remaining)
Injunction Viability (35 U.S.C. § 283) Active Threat
Respondent Inventor Fintan Keegan et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

62 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Harness Dickey (St. Louis)
Customer Number 28997
Address 7700 Bonhomme, Suite 400, St. Louis, MO, 63105, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
27382 G. Schivley +1 248-641-1600
29752 Paul Keller +1 248-641-1600
30332 Gerald Welch +1 469-777-5410
30612 Michael Brennan +1 248-641-1600
30692 David Suter +1 248-641-1600
31306 W. R. Taylor +1 248-641-1600
31441 Bryan Wheelock +1 314-726-7505
33686 Mark Elchuk +1 248-641-1600

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 9 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (9 found):
PTAB: 9
USPTO PTAB Trial 2019-02-19
IPR2019-00698

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00697

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00693

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9561177)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00692

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9561177)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00691

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9561177)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00690

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9468747)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00689

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9468747)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00688

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9468747)
Status: Final Written Decision
USPTO PTAB Trial 2019-02-19
IPR2019-00687

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9211253)
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

117
15

Notice of Refund Paper

2019-10-29 FILING PARTY: BOARD
14

PETITIONER NALOX-1 PHARMACEUTICALS, LLC¿¿¿S REQUEST FOR REFUND OF POST-INSTITUTION FEES Paper

2019-10-25 FILING PARTY: PETITIONER
13

Trial Instituted Document Paper

2019-10-16 FILING PARTY: BOARD
12

PATENT OWNER'S RESPONSE TO PETITIONER'S NOTICE Paper

2019-08-12 FILING PARTY: PATENT OWN
11

Petitioner's Notice Paper

2019-08-05 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc